StemBios Technologies, Inc. is a biotechnology development company focused on the development of proprietary, novel SB Cells^® (StemBios cells) used for therapeutic cell banking and cellular healing, therapeutic approaches to cure common degenerative diseases.

StemBios Technologies, Inc. has discovered adult pluripotent stem cells, dubbed SB Cells^®, from adult blood and bone marrow. Our SB Cells^® have specific markers and can be cultured in vitro in large quantities. SB Cells^® possess all the advantages of embryonic stem cells. However, unlike embryonic stems, SB Cells^® do not cause teratoma or immune rejection. More significantly, SB Cells^® have the potential to differentiate into Endoderm, Mesoderm, and Ectoderm cells both in vivo and in vitro.

StemBios Technologies, Inc. aims to utilize its proprietary SB Cells^® and establish a cell banking system offering SB Cells^® storage for our customers. Stored SB Cells^® can be used for cell therapy in curing neurodegenerative diseases such as Parkinson’s and Alzheimer’s as well as cardiovascular, metabolic, and autoimmune diseases. Other applications include research and development towards an artificial liver system, albumin products and cancer vaccines in addition to anti-aging products.